>

Nesli Basgoz - Allergan Plc Independent Director

<div class='circular--portrait' style='background:#0D8ECF;color: white;font-size:4em;padding-top: 25px;;'>AL</div>
AGN -- USA Stock  

Fiscal Quarter End: March 31, 2020  

  Director
Dr. Nesli Basgoz, M.D. is Independent Director of Allergan Plc. Dr. Basgoz joined the Board of Directors in July 2014 following the Companys acquisition of Forest Laboratories, Inc., having served as a member of the Board of Directors of Forest beginning 2006. Dr. Basgoz is currently the Associate Chief and Clinical Director, Division of Infectious Diseases at Massachusetts General Hospital, a role she has held since 2001. In addition, Dr. Basgoz is an Associate Professor of Medicine at Harvard Medical School
Age: 60  Director Since 2014      
862 261 7000  http://www.allergan.com
Basgoz earned her MD degree and completed her residency in internal medicine at Northwestern University Medical School. She also completed a fellowship in the Infectious Diseases Division at the University of California at San Francisco. She is board certified in both infectious diseases and internal medicine.

Nesli Basgoz Latest Insider Activity

Management Efficiency

The company has 23.08 B in debt with debt to equity (D/E) ratio of 39.4 . This implies that the company may be unable to create cash to meet all of its financial commitments. Allergan Plc has Current Ratio of 0.98 suggesting that it has not enough short term capital to pay financial commitments when the payables are due.

Similar Executives

Showing few of many executives

DIRECTOR Since

Philip HamptonGlaxoSmithKline PLC
2015
Judy LewentGlaxoSmithKline PLC
2011
Jennifer DoudnaJohnson Johnson
2018
John MadiganGilead Sciences
2005
Ronald WilliamsJohnson Johnson
2011
Stephanie BurnsGlaxoSmithKline PLC
2007
Don CornwellPfizer
1997
Ann FudgeNovartis AG
2008
Per WoldOlsenGilead Sciences
2010
Rochelle LazarusMerck Company
2004
Michael GrobsteinBristol Myers Squibb Company
2007
Shriti VaderaAstrazeneca PLC
2011
Ian DavisJohnson Johnson
2010
Srikant DatarNovartis AG
2003
Lewis CampbellBristol Myers Squibb Company
2014
Shantanu NarayenPfizer
2013
Hans WijersGlaxoSmithKline PLC
2013
Dan LittmanPfizer
2018
Wyllie CornwellPfizer
1997
Katherine BaickerEli Lilly And Company
2011
Jesse GoodmanGlaxoSmithKline PLC
2017

Company Summary

Allergan plc, a pharmaceutical company, develops, manufactures, and commercializes branded pharmaceutical, device, biologic, surgical, and regenerative medicine products worldwide. The company was formerly known as Actavis plc and changed its name to Allergan plc in June 2015. Allergan Plc operates under Drug Manufacturers - General classification in USA and is traded on BATS Exchange. It employs 17400 people.Allergan Plc (AGN) is traded on BATS Exchange in USA. It is located in Clonshaugh Business and Technology Park and employs 17,400 people. Allergan Plc is listed under Pharmaceutical Products category by Fama And French industry classification.

Allergan Plc Leadership Team

Matthew Walsh, Chief Financial Officer, Executive Vice PresidentView
Robert Bailey, Chief Legal Officer and Corporate SecretaryView
Robert Stewart, Executive VP and President of Generic and Global OperationsView
Ronald Taylor, Independent DirectorView
Adriane Brown, Independent DirectorView
William Meury, Executive Vice President, Chief Commercial OfficerView
Brenton Saunders, Chairman of the Board, President, Chief Executive OfficerView
Wayne Swanton, Executive Vice President - Global OperationsView
Robert Hugin, Independent DirectorView
Nicholson, Chief R&D OfficerView
Christopher Bodine, Independent DirectorView
Karen Ling, Chief Human Resource Officer, Executive Vice PresidentView
Michael Gallagher, Lead Independent DirectorView
Paul Bisaro, Executive ChairmanView
Thomas Freyman, Independent DirectorView
Catherine Klema, Lead Independent DirectorView
James DArecca, Chief Accounting OfficerView
Christopher Coughlin, Lead Independent DirectorView
Nesli Basgoz, Independent DirectorView
Philippe Schaison, Executive Vice President and President Allergan MedicalView
Maria Hilado, CFO and Executive VPView
Joseph Boccuzi, Independent DirectorView
Patrick OSullivan, Independent DirectorView
Fred Weiss, Independent DirectorView
A Bailey, Executive Vice President, Chief Legal Officer and Corporate SecretaryView
Alex Kelly, Chief Communications OfficerView
CDavid Nicholson, Executive Vice President, Chief R&D OfficerView
Carol Davidson, Independent DirectorView
Michael Greenberg, Independent DirectorView
Ron Taylor, Independent DirectorView
Jonathon Kellerman, Executive Vice President Chief Compliance OfficerView
Paul Navarre, Executive Vice President and President International BrandsView
James Bloem, Independent DirectorView
Karina Calzadilla, IR Contact OfficerView
Peter McDonnell, Independent DirectorView

Stock Performance Indicators

Current Sentiment - AGN

Allergan Plc Investor Sentiment

Predominant part of Macroaxis users are presently bullish on Allergan Plc. What is your sentiment towards investing in Allergan Plc? Are you bullish or bearish?
Bullish
Bearish
98% Bullish
2% Bearish
Skip

Allergan Plc Pair Correlation

Equities Pair Trading Analysis

Correlation analysis and pair trading evaluation for Allergan Plc and Bristol Myers Squibb. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  
Please continue to Trending Equities. Please also try Content Syndication module to quickly integrate customizable finance content to your own investment portal.